200 related articles for article (PubMed ID: 6235653)
21. [Bone marrow regulatory factors (BMRF) and the transplanting of bone marrow: a model of morphostasis and immunity].
Pierpaoli W; Maestroni GJ
Fiziol Cheloveka; 1984; 10(2):234-41. PubMed ID: 6398233
[No Abstract] [Full Text] [Related]
22. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
Wood ML; Monaco AP; Gozzo JJ; Liegeois A
Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
[No Abstract] [Full Text] [Related]
23. [Suppressor action of the liver in the graft vs. host reaction].
Divanian Kh
Eksp Med Morfol; 1985; 24(2):25-30. PubMed ID: 2933241
[No Abstract] [Full Text] [Related]
24. In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.
Atkinson K; Storb R; Weiden PL; Deeg HJ; Gerhard-Miller L; Thomas ED
J Immunol; 1980 Apr; 124(4):1808-14. PubMed ID: 6154081
[No Abstract] [Full Text] [Related]
25. Mixed allogeneic chimerism as an approach to transplantation tolerance.
Sykes M; Sachs DH
Immunol Today; 1988 Jan; 9(1):23-7. PubMed ID: 3076756
[No Abstract] [Full Text] [Related]
26. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.
Helg C; Chapuis B; Bolle JF; Morel P; Salomon D; Roux E; Antonioli V; Jeannet M; Leski M
Transplantation; 1994 Dec; 58(12):1420-2. PubMed ID: 7809937
[No Abstract] [Full Text] [Related]
27. Chimerism and thoracic organ transplantation.
Gammie JS; Colson YL; Griffith BP; Pham SM
Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):149-55. PubMed ID: 8672568
[TBL] [Abstract][Full Text] [Related]
28. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow transplantation.
Storb R; Santos GW
Transplant Proc; 1979 Mar; 11(1):1163-6. PubMed ID: 36699
[No Abstract] [Full Text] [Related]
30. [Immunologic problems in allogenic and autologous bone marrow transplantation].
Schwenke H; Helbig W; Kubel M; Schultze W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
[No Abstract] [Full Text] [Related]
31. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
[TBL] [Abstract][Full Text] [Related]
32. Effector mechanisms and graft-versus-host disease.
Elkins WL
Transplant Proc; 1978 Mar; 10(1):15-7. PubMed ID: 24906
[No Abstract] [Full Text] [Related]
33. Tolerance induction and sensitization by preincubation of bone marrow with allogeneic erythrocytes.
Uphoff DE
J Natl Cancer Inst; 1971 Dec; 47(6):1223-31. PubMed ID: 4399195
[No Abstract] [Full Text] [Related]
34. Mechanism of the maintenance of transplantation tolerance.
Moran T; Dittmer J; Bennett M
Transplant Proc; 1981 Mar; 13(1 Pt 1):611-3. PubMed ID: 6455804
[No Abstract] [Full Text] [Related]
35. Induction of allogeneic unresponsiveness by supralethal irradiation and bone marrow reconstitution.
Rapaport FT; Bachvaroff RJ; Akiyama N; Sato T
Transplant Proc; 1980 Sep; 12(3):473-6. PubMed ID: 7013179
[No Abstract] [Full Text] [Related]
36. [Hematopoiesis in radiochimeras].
Zaretzkaya J; Kovalchouk L; Kvasnikova L
Rev Fr Etud Clin Biol; 1969; 14(6):590-4. PubMed ID: 4390465
[No Abstract] [Full Text] [Related]
37. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
38. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
Wood ML; Gozzo JJ; Monaco AP
Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
[No Abstract] [Full Text] [Related]
39. Induction of tolerance with cyclosporin A.
Tutschka PJ
Prog Clin Biol Res; 1986; 224():209-26. PubMed ID: 2948193
[No Abstract] [Full Text] [Related]
40. Tolerance induction to islet allografts following infusion of perforin deficient bone marrow.
Selvaggi G; Inverardi L; Levy RB; Mintz DH; Podack ER; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3193. PubMed ID: 8539907
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
